✦ LIBER ✦

Screening for trisomy 21: The significance of a positive second trimester serum screening in women with low risk nuchal translucency scan

✍ Scribed by A. San; K. Langford; B. Auld; D. Maxwell

Book ID: 117123541
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 159 KB
Volume: 70
Category: Article
ISSN: 0020-7292
DOI: 10.1016/s0020-7292(00)81546-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential screening for trisomy 21 by n

Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population

✍ Dr K. Schuchter; E. Hafner; G. Stangl; E. Ogris; K. Philipp 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Screening for fetal trisomy 21 in the fi

Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free β-hCG and fetal nuchal translucency thickness

✍ P. L. Noble; H. D. Abraha; R. J. M. Snijders; R. Sherwood; Professor K. H. Nicol 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

Evaluation of pregnancy outcome in euplo

Evaluation of pregnancy outcome in euploid fetuses with a screen positive second trimester maternal serum screen for trisomy 18

✍ Calla Holmgren; Alexandra Grosvenor; Kristy Nelson; Nancy Rose 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Screening for trisomy 21 in twin pregnan

Screening for trisomy 21 in twin pregnancies in the first trimester using free β-hCG and PAPP-A, combined with fetal nuchal translucency thickness

✍ Kevin Spencer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

In the ®rst trimester of pregnancy the biochemical markers free b-hCG and pregnancy associated plasma protein-A (PAPP-A) are used for the prenatal screening of trisomy 21, either alone or in combination with nuchal translucency (NT) thickness. In this study, I have analysed the distribution of these

OC113: Prevalence and risk of trisomy 21

OC113: Prevalence and risk of trisomy 21 following negative (< 1/250) combined screening with maternal age, nuchal translucency and maternal serum markers at 11–14 weeks. A role for the genetic scan?

✍ J. P. Bernard; L. Bussieres; P. Rozenberg; Y. Ville 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Miscarriage after a normal scan at 12–14

Miscarriage after a normal scan at 12–14 gestational weeks in women at low risk of carrying a fetus with chromosomal anomaly according to nuchal translucency screening

✍ M. Westin; K. Källén; S. Saltvedt; H. Almström; C. Grunewald; L. Valentin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB